Cyte Global

CYTE is an innovative, contract research organisation (CRO) specialising in cardiovascular disease. We deliver world-leading clinical trials and real-world studies that are helping to redefine how these conditions are identified and treated. Powered by our world renowned Scientific Advisory Board and a global network of over sites in 45 countries, we partner with leading industry and research institutes to enable the development of innovative medicines and shifting the treatment paradigm in cardiovascular disease. CYTE was established in 2017 as the delivery arm of the Thrombosis Research Institute (TRI) in London. TRI has been conducting scientific, clinical and outcomes research in cardiovascular disease for over 30 years. CYTE now delivers these world-leading capabilities in partnership with sponsors around the world.